BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol 2020;8:535-45. [PMID: 32445740 DOI: 10.1016/S2213-8587(20)30118-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Jiang Z, Yu X, Shao Y, Liu H, Wu S, Kong L, Wang Z. Comparative efficacy and safety of traditional Chinese patent medicine for cognitive dysfunction in diabetic cognitive dysfunction: A protocol for systematic review and Bayesian network meta-analysis. Medicine (Baltimore) 2022;101:e28946. [PMID: 35451386 DOI: 10.1097/MD.0000000000028946] [Reference Citation Analysis]
2 Yang Y, Zhao JJ, Yu XF. Expert Consensus on Cognitive Dysfunction in Diabetes. Curr Med Sci 2022. [PMID: 35290601 DOI: 10.1007/s11596-022-2549-9] [Reference Citation Analysis]
3 Zhou XY, Ying CJ, Hu B, Zhang YS, Gan T, Zhu YD, Wang N, Li AA, Song YJ. Receptor for advanced glycation end products aggravates cognitive deficits in type 2 diabetes through binding of C-terminal AAs 2-5 to mitogen-activated protein kinase kinase 3 (MKK3) and facilitation of MEKK3-MKK3-p38 module assembly. Aging Cell 2022;:e13543. [PMID: 35080104 DOI: 10.1111/acel.13543] [Reference Citation Analysis]
4 Siru R, Burkhardt MS, Davis WA, Hiew J, Manning L, Ritter JC, Norman PE, Makepeace A, Fegan PG, Bruce DG, Davis TME, Hamilton EJ. Cognitive Impairment in People with Diabetes-Related Foot Ulceration. J Clin Med 2021;10:2808. [PMID: 34202360 DOI: 10.3390/jcm10132808] [Reference Citation Analysis]
5 Mani V, Arfeen M, Sajid S, Almogbel Y. Aqueous Ajwa dates seeds extract improves memory impairment in type-2 diabetes mellitus rats by reducing blood glucose levels and enhancing brain cholinergic transmission. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2021.12.060] [Reference Citation Analysis]
6 Mone P, Gambardella J, Lombardi A, Pansini A, De Gennaro S, Leo AL, Famiglietti M, Marro A, Morgante M, Frullone S, De Luca A, Santulli G. Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults. Cardiovasc Diabetol 2022;21. [DOI: 10.1186/s12933-021-01442-z] [Reference Citation Analysis]
7 Lopes ROP, Santos JC, Oliveira HC, Campos JF, Primo CC, Lopes CT, Brandão MAG. Risk for Imbalanced Blood Glucose Pattern: Construct Analysis and Nursing Diagnosis Proposal. Clin Nurs Res 2022;:10547738211073395. [PMID: 35100892 DOI: 10.1177/10547738211073395] [Reference Citation Analysis]
8 Chen R, Zeng Y, Xiao W, Zhang L, Shu Y. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment. Front Endocrinol (Lausanne) 2021;12:665309. [PMID: 34276557 DOI: 10.3389/fendo.2021.665309] [Reference Citation Analysis]
9 Qian H, Qin D, Qi S, Teng Y, Li C, Yao Y, Wu J. Less Is Better: Single-Digit Brain Functional Connections Predict T2DM and T2DM-Induced Cognitive Impairment. Front Neurosci 2020;14:588684. [PMID: 33505236 DOI: 10.3389/fnins.2020.588684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Korai SA, Ranieri F, Di Lazzaro V, Papa M, Cirillo G. Neurobiological After-Effects of Low Intensity Transcranial Electric Stimulation of the Human Nervous System: From Basic Mechanisms to Metaplasticity. Front Neurol 2021;12:587771. [PMID: 33658972 DOI: 10.3389/fneur.2021.587771] [Reference Citation Analysis]
11 Wu M, Pu K, Wang N, Wang Y, Li Y, Wang Y, Duan N, Zhai Q, Wang Q. Label-free in vivo assessment of brain mitochondrial redox states during the development of diabetic cognitive impairment using Raman spectroscopy. Free Radic Biol Med 2022:S0891-5849(22)00100-9. [PMID: 35339608 DOI: 10.1016/j.freeradbiomed.2022.03.005] [Reference Citation Analysis]
12 Chen Y, Pan Y, Kang S, Lu J, Tan X, Liang Y, Lyu W, Li Y, Huang H, Qin C, Zhu Z, Li S, Qiu S. Identifying Type 2 Diabetic Brains by Investigating Disease-Related Structural Changes in Magnetic Resonance Imaging. Front Neurosci 2021;15:728874. [PMID: 34764850 DOI: 10.3389/fnins.2021.728874] [Reference Citation Analysis]
13 Li X, Yin Y, Li W, Li S, Zhang D, Liu Z. Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse. Bioengineered 2022;13:9387-96. [PMID: 35389830 DOI: 10.1080/21655979.2022.2055699] [Reference Citation Analysis]
14 Pu K, Wu M, Jiang T, Zhang Y, Ye M, Sun J, Ma H, Zhai Q, Wang Q. Involvement of Paired Immunoglobulin-like Receptor B in Diabetes-Associated Cognitive Dysfunction Through Modulation of Axon Outgrowth and Dendritic Remodeling. Mol Neurobiol 2022. [PMID: 35091963 DOI: 10.1007/s12035-021-02679-1] [Reference Citation Analysis]
15 Marunaka Y. Roles of interstitial fluid pH and weak organic acids in development and amelioration of insulin resistance. Biochem Soc Trans 2021;49:715-26. [PMID: 33769491 DOI: 10.1042/BST20200667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Song J, Bai H, Xu H, Xing Y, Chen S, Seixas A. HbA1c Variability and the Risk of Dementia in Patients with Diabetes: A Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/7706330] [Reference Citation Analysis]
17 Weng Z, Chen Y, Lv J, Wang M, Chen Z, Zhou W, Shen X, Zhan L, Wang F, Xiao J. A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/4289383] [Reference Citation Analysis]
18 Tanashyan MM, Surkova EV, Antonova KV, Lagoda OV, Naminov AV, Berdnikovich ES, Fedin PA, Titkova II. Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases. Terapevticheskii arkhiv 2021;93:1179-85. [DOI: 10.26442/00403660.2021.10.201108] [Reference Citation Analysis]
19 Bellido V, Martínez J, Calvo F, Villarroel A, Lecumberri E, Moreno J, Morillas C, Rodrigo S, Izarra A, Lecube A. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications. Diabetes Ther 2022. [PMID: 35338446 DOI: 10.1007/s13300-022-01237-9] [Reference Citation Analysis]
20 Mirghani H, Aljohani S, Albalawi A. Dementia and Adherence to Anti-Diabetic Medications: A Meta-Analysis. Cureus 2021;13:e14611. [PMID: 34040911 DOI: 10.7759/cureus.14611] [Reference Citation Analysis]
21 Cheng D, Zhao X, Yang S, Wang G, Ning G. Association Between Diabetic Retinopathy and Cognitive Impairment: A Systematic Review and Meta-Analysis. Front Aging Neurosci 2021;13:692911. [PMID: 34276346 DOI: 10.3389/fnagi.2021.692911] [Reference Citation Analysis]
22 Wang J, Ma L, Liu G, Bai W, Ai K, Zhang P, Hu W, Zhang J. Tractography in Type 2 Diabetes Mellitus With Subjective Memory Complaints: A Diffusion Tensor Imaging Study. Front Neurosci 2022;15:800420. [DOI: 10.3389/fnins.2021.800420] [Reference Citation Analysis]
23 Cai XT, Zhu Q, Liu SS, Wang MR, Wu T, Hong J, Hu JL, Li N. Associations Between the Metabolic Score for Insulin Resistance Index and the Risk of Type 2 Diabetes Mellitus Among Non-Obese Adults: Insights from a Population-Based Cohort Study. Int J Gen Med 2021;14:7729-40. [PMID: 34785931 DOI: 10.2147/IJGM.S336990] [Reference Citation Analysis]
24 Lee TH, Yau SY. From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions. Int J Mol Sci 2020;22:E201. [PMID: 33379163 DOI: 10.3390/ijms22010201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Obadia N, Andrade G, Leardini-Tristão M, Albuquerque L, Garcia C, Lima F, Daleprane J, Castro-Faria-Neto HC, Tibiriçá E, Estato V. TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice. J Neuroinflammation 2022;19:104. [PMID: 35488354 DOI: 10.1186/s12974-022-02465-3] [Reference Citation Analysis]
26 Phoenix A, Chandran R, Ergul A. Cerebral Microvascular Senescence and Inflammation in Diabetes. Front Physiol 2022;13:864758. [DOI: 10.3389/fphys.2022.864758] [Reference Citation Analysis]
27 Xu D, Yu Y, Xu Y, Ge J. Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient. Diabetes Metab Syndr Obes 2021;14:3555-66. [PMID: 34408457 DOI: 10.2147/DMSO.S323009] [Reference Citation Analysis]
28 Lin L, Wu Y, Chen Z, Huang L, Wang L, Liu L. Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction. Front Aging Neurosci 2021;13:775244. [PMID: 34899278 DOI: 10.3389/fnagi.2021.775244] [Reference Citation Analysis]
29 Rizzo MR, Di Meo I, Polito R, Auriemma MC, Gambardella A, di Mauro G, Capuano A, Paolisso G. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment. Pharmacol Res 2022;176:106062. [PMID: 35017046 DOI: 10.1016/j.phrs.2022.106062] [Reference Citation Analysis]